Travere Therapeutics (TVTX) Change in Inventory (2014 - 2026)

Travere Therapeutics (TVTX) has 13 years of Change in Inventory data on file, last reported at $742000.0 in Q1 2026.

• Quarterly Change in Inventory rose 120.25% year-over-year to $742000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$610000.0 (up 64.47% YoY) and the FY2025 annual result came in at -$5.0 million, down 233.02% from the prior year.
• Change in Inventory improved to $742000.0 in Q1 2026, from -$1.2 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $22.4 million in Q4 2023 to a low of -$3.7 million in Q1 2025.
• A 5-year average of $2.4 million and a median of $285000.0 in 2024 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory soared 59028.95% — and 2025, when it tumbled 512.98%.
• Tracing TVTX's Change in Inventory over 5 years: stood at -$38000.0 in 2022, then soared by 59028.95% to $22.4 million in 2023, then plunged by 98.73% to $285000.0 in 2024, then plunged by 512.98% to -$1.2 million in 2025, then soared by 163.04% to $742000.0 in 2026.
• The last three Change in Inventory figures came in at $742000.0 (Q1 2026), -$1.2 million (Q4 2025), and -$194000.0 (Q3 2025), per Business Quant data.